Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations

NCT02705846 · clinicaltrials.gov ↗
RECRUITING
Status
4260
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institute of Cancer Research, United Kingdom